Mark your Calendars – Peer Review Week is Coming!

Come learn more about the review process in scholarly publishing and how the MSK Library can support your research needs by attending one (or all!) of our scheduled events during Peer Review Week 2016 (September 19 – 25).

The events schedule is still being ironed out, but activities include ORCID@MSK – unique researcher identifier, Synapse – connection to MSK authors, a workshop on evaluating scholarly journals, and overviews of key resources to up your publishing workflow efficiencies. The week will consist of walk-in clinics, formal training, virtual exploration, and an ORCID-themed table at this year’s IT Expo (scheduled for Wednesday, September 21). Stop by our table to create an ORCID iD on the spot, or get tips for maintaining and utilizing your ORCID iD. There will also be cookies/granola bars at these events along with an ongoing raffle to win one of three Amazon gift cards! (Hint: the more events you attend, the higher your chances are of winning)

Stay tuned for more information about our schedule during Peer Review Week and don’t forget to mark your calendars for this special event! Oh, and join the conversation on Twitter using #PeerRevWk16 or #RecognizeReview.

Guess What We’ve Been Up To? Find Out By Viewing Our 2014-2015 Library Progress Report

 I am delighted to present to our readers and library users our Library Progress Report highlighting our activities for 2014 and 2015. This report is a celebration of our accomplishments and marks our progress over the past two years. Within these pages, we share information about our operations, staff publications, library services, and usage metrics that showcase the value of our collection and services.

I think that you’ll especially enjoy reading about our collaborative projects with users. Most of all, I hope this report will spark interest in MSK staff to take a few moments to explore a new resource, service, or include us on a future team initiative.

If you want to learn more about the MSK Library or the services we provide, don’t hesitate to contact me.

Donna Gibson
Director of Library Services

MSK Research in the News

The ASCO, the SSO, and the ASTRO have come together and issued a joint guideline on what constitutes a successful surgery for ductal carcinoma in situ (DCIS) in terms of having cancer-free margins on the removed tissue. Chief of Breast Service at MSK, Dr. Monica Morrow was the lead author on this meta-analysis of over 20 studies involving almost 8,000 patients. They concluded that a 2mm margin should be adequate for breast conserving surgery and is associated with low rates of ipsilateral tumor recurrence.

A recent JAMA Oncology report showed that mutations in estrogen receptors impacted the progression-free survival of breast cancer patients. Dr. Sarat Chandarlapaty and his colleagues used cDNA assays to identify two mutations: D538G and Y5378. For women with these mutations who were treated with Aromatase inhibitors, their progression-free survival rates were the similar to the women with neither mutation. “While this study hasn’t found a “cure” for breast cancer, it suggests a new means of providing a longer life for women with ER+ tumors — even if metastasis has occurred.”

A new study in the Journal of Hepatology by Dr Ghassan Abou-Alfa found that Codrituzumab was not effective for patients who had already failed treatment for hepatocellular carcinoma. However, higher doses of Codrituzumab or selecting patients with higher CD16 and glypican-3 levels could improve patient outcomes.